These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8795120)

  • 1. Treatment of rheumatoid arthritis with biologics.
    Panayi GS
    Schweiz Med Wochenschr Suppl; 1996; 80():22S-23S. PubMed ID: 8795120
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel therapies for treatment of rheumatoid arthritis.
    Piascik P
    J Am Pharm Assoc (Wash); 1997; NS37(1):14-6. PubMed ID: 9040165
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological agents in rheumatoid arthritis.
    Weinblatt ME
    J Rheumatol Suppl; 1992 Jan; 32():85-8; discussion 88-91. PubMed ID: 1613738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative overview of safety of the biologics in rheumatoid arthritis.
    Khraishi M
    J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1 trap go-ahead.
    Ratner M
    Nat Biotechnol; 2008 May; 26(5):485. PubMed ID: 18464767
    [No Abstract]   [Full Text] [Related]  

  • 6. Expanding role of biologic agents in rheumatoid arthritis.
    Kalden JR
    J Rheumatol Suppl; 2002 Nov; 66():27-37. PubMed ID: 12435166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New biologics for psoriasis and psoriatic arthritis.
    Rozenblit M; Lebwohl M
    Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring the impact of managed care plans on the use of biologics.
    Furst DE
    Arthritis Rheum; 2005 Jun; 53(3):318-9. PubMed ID: 15934125
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic inflammatory diseases. Early biologics therapy is cost effective].
    MMW Fortschr Med; 2010 May; 152(21):78-9. PubMed ID: 20608134
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biologics in rheumatology. Targeted therapy--and what must be considered].
    Fischer A
    MMW Fortschr Med; 2010 Sep; 152(38):12. PubMed ID: 20960670
    [No Abstract]   [Full Text] [Related]  

  • 11. BiP: a new biologic immunomodulator for the treatment of rheumatoid arthritis.
    Panayi G; Corrigall V
    Autoimmun Rev; 2004 Jun; 3 Suppl 1():S16-7. PubMed ID: 15309771
    [No Abstract]   [Full Text] [Related]  

  • 12. Joint approach.
    Palmer K
    Minn Med; 2009 Sep; 92(9):22-5. PubMed ID: 19877473
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune Mechanisms and Novel Targets in Rheumatoid Arthritis.
    Venuturupalli S
    Immunol Allergy Clin North Am; 2017 May; 37(2):301-313. PubMed ID: 28366478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel biologic approaches to the treatment of rheumatoid arthritis.
    Sany J
    Rev Rhum Engl Ed; 1999 Nov; 66(11):548-59. PubMed ID: 10591116
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluating biologic agents in rheumatoid arthritis: a framework for clinical trials.
    Strand V; Scott DL; Panayi GS
    J Rheumatol; 1994 Aug; 21(8):1390-2. PubMed ID: 7983635
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of early rheumatoid arthritis in developing countries. Biologics or disease-modifying anti-rheumatic drugs?
    Yen JH
    Biomed Pharmacother; 2006 Dec; 60(10):688-92. PubMed ID: 17049202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid arthritis initial therapy: unanswered questions.
    O'Dell J
    J Rheumatol Suppl; 2005 Jan; 72():14-6. PubMed ID: 15660457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rheumatoid arthritis: early aggressive therapy including biologicals -- pro].
    Rubbert-Roth A
    Dtsch Med Wochenschr; 2005 Aug; 130(33):1900. PubMed ID: 16118736
    [No Abstract]   [Full Text] [Related]  

  • 19. Examining the efficacy of biologic therapy: are there real differences?
    Fleischmann RM
    J Rheumatol Suppl; 2002 Sep; 65():27-32. PubMed ID: 12236619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are the risks of biologic therapy in rheumatoid arthritis? An update on safety.
    Weisman MH
    J Rheumatol Suppl; 2002 Sep; 65():33-8. PubMed ID: 12236621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.